Individualized higher dose of 70–75 Gy using five-fraction robotic stereotactic radiotherapy for non-small-cell lung cancer: A feasibility study

References

• Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 1989; 16: 247–255
   PubMed Web of Science ®Google Scholar
• Coy P, Kennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer 1980; 45: 698–702
   PubMed Web of Science ®Google Scholar
• Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Salenius S, Rashid M, Dosani RA, Mestas G, Siegel AD, Chadha TT, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992; 24: 3–9
   PubMed Web of Science ®Google Scholar
• Haffty BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RE. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1988; 15: 69–73
   PubMed Web of Science ®Google Scholar
• Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27: 517–523
   PubMed Web of Science ®Google Scholar
• Dosoretz DE, Galmarini D, Rubenstein JH, Katin MJ, Blitzer PH, Salenius SA, Dosani RA, Rashid M, Mestas G, Hannan SE, et al. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993; 27: 507–516
   PubMed Web of Science ®Google Scholar
• Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Galmarini DH, Garton GR, Salenius SA. Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol 1996; 6: 98–104
   PubMed Web of Science ®Google Scholar
• Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998; 40: 149–154
   PubMed Web of Science ®Google Scholar
• Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615–622, discussion 622–613
   PubMed Web of Science ®Google Scholar
• Curran WJ, Jr, Moldofsky PJ, Solin LJ. Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function. Cancer 1990; 65: 2488–2493
   PubMed Web of Science ®Google Scholar
• Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996; 34: 297–302
   PubMed Web of Science ®Google Scholar
• Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, Littles JF, Martinez FJ, Francis IR, Quint LE, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37: 1079–1085
   PubMed Web of Science ®Google Scholar
• Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 1996; 41: 41–44
   PubMed Web of Science ®Google Scholar
• Williams TE, Thomas CR, Jr, Turrisi AT, 3rd. Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol 2000; 10: 315–323
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–870
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677–683
   PubMed Web of Science ®Google Scholar
• Fowler JF. Comment on “Magical protons?” editorial by Dr. Michael Goitein (Int J Radiat Oncol Biol Phys 2008;70:654–656). Int J Radiat Oncol Biol Phys 2008;72:1270–1271.
   Google Scholar
• Fowler JF. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling. Int J Radiat Oncol Biol Phys 2009; 73: 1532–1537
   PubMed Web of Science ®Google Scholar
• Brown WT, Wu X, Amendola B, Perman M, Han H, Fayad F, García S, Lewin A, Abitbol A, de la Zerda A, et al. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation – CyberKnife. Cancer J 2007; 13: 87–94
   PubMed Web of Science ®Google Scholar
• Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, et al. CyberKnife radiosurgery for stage I lung cancer: Results at 36 months. Clin Lung Cancer 2007; 8: 488–492
   PubMed Web of Science ®Google Scholar
• Brown WT, Wu X, Fayad F, Fowler JF, García S, Monterroso MI, de la Zerda A, Schwade JG. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Clin Oncol (R Coll Radiol) 2009; 21: 623–631
   PubMed Web of Science ®Google Scholar
• Brown WT, Wu X, Fowler JF, García S, Fayad F, Amendola BE, de la Zerda A, Schwade JG. Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months. South Med J 2008; 101: 376–382
   PubMed Web of Science ®Google Scholar
• Brown WT, Wu X, Wen BC, Fowler JF, Fayad F, Amendola BE, García S, de la Zerda A, Huang Z, Schwade JG. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors. Comput Aided Surg 2007; 12: 253–261
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: A meta-analysis. Br J Cancer 2005; 92: 1033–1037
   PubMed Web of Science ®Google Scholar
• Love N. Conversations with oncology investigators: Bridging the gap between research and patient care. Lung Cancer Update; 2009.
   Google Scholar
• Grills IS, Fitch DL, Goldstein NS, Yan D, Chmielewski GW, Welsh RJ, Kestin LL. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 334–341
   PubMed Web of Science ®Google Scholar
• Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, Wloch J, Ye H, Kestin LL. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2009; 28: 928–935
   Web of Science ®Google Scholar
• Hayman JA, Martel MK, Ten Haken RK, Normolle DP, Todd RF, III, Littles JF, Sullivan MA, Possert PW, Turrisi AT, Lichter AS. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 2001; 19: 127–136
   PubMed Web of Science ®Google Scholar
• Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiother Oncol 2010; 94: 1–11
   PubMed Web of Science ®Google Scholar
• Onimaru R, Fujino M, Yamazaki K, Onodera Y, Taguchi H, Katoh N, Hommura F, Oizumi S, Nishimura M, Shirato H. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 374–381
   PubMed Web of Science ®Google Scholar
• Koto M, Takai Y, Ogawa Y, Matsushita H, Takeda K, Takahashi C, Britton KR, Jingu K, Takai K, Mitsuva M, et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2007; 85: 429–434
   PubMed Web of Science ®Google Scholar
• Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946–1955
   PubMed Web of Science ®Google Scholar
• McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005; 63: 1010–1015
   PubMed Web of Science ®Google Scholar
• Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001; 49: 23–33
   PubMed Web of Science ®Google Scholar
• Fowler JF. Linear quadratics is alive and well: In regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847–852). Int J Radiat Oncol Biol Phys 2008;72:957; author reply 958.
   Google Scholar
• Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung SH, Silvestri GA, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 126: 1943–1951
   PubMed Web of Science ®Google Scholar
• Errett LE, Wilson J, Chiu RC, Munro DD. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg 1985; 90: 656–661
   PubMed Web of Science ®Google Scholar
• Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833–4839
   PubMed Web of Science ®Google Scholar
• Brown WT, Perman M, Wu X, Yang J, Schwade JG. Image-guided robotic stereotactic radiosurgery for treatment of lung tumors. Robotic Radiosurgery, RF Mould, RA Schulz, RD Bucholz, GJ Gagnon, PC Gerszten, JJ Kresl, PC Levendag. CyberKnife Society Press, Sunnyvale, CA 2005; 1: 255–268
   Google Scholar